Biologics take aim at helping statin-intolerant patientsNew drug class shows promise in phase III trials Careful with that SSRI dose Doctors have mixed views of their drugstore colleagues Survey of physicians reveals that, as with all relationships, there is the good, the bad, and even the ugly. LETTER: Dr. Sam Ozersky's response to the cover Five tips for discussing genetic tests with patients Understanding what a patient is looking for and explaining the implications are important aspects of genetic testing OTC report: Getting the better of brand extension Global study on actinic keratosis therapies Panel reviews first global study looking at physician perceptions in treatment of AK. Greater awareness helps drive psoriasis market growth Report predicts substantial growth for the systemic psoriasis market. LETTER: We should blame ourselves too for waits New Brunswick's new drug plan now providing coverage Plan providing drug coverage for the uninsured is voluntary in its first year before becoming mandatory. New frontiers in tissue engineering Success reported with vagina, nostril reconstruction One way to handle (possibly) manipulative patients A kind, thorough approach lets you distinguish between drug-seekers and those patients who truly want help First Previous 1259 1260 1261 1262 1263 Next Last
